Indonesia's Bio Farma says not yet able to determine Sinovac vaccine efficacy

Indonesia's state-owned pharmaceutical company Bio Farma said today that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 percent efficacy.

"Our clinical trial team found, within one month, that the interim data shows up to 97 percent for its efficacy," said Iwan Setiawan, a spokesperson for Bio Farma, at a news conference...